➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School

Last Updated: August 5, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Methylmalonic Acid

Email this page to a colleague

« Back to Dashboard

What is the drug development status for Methylmalonic Acid?

Methylmalonic Acid is an investigational drug.

There have been 14 clinical trials for Methylmalonic Acid. The most recent clinical trial was a Phase 3 trial, which was initiated on January 1st 2006.

The most common disease conditions in clinical trials are Amino Acid Metabolism, Inborn Errors, Vitamin B 12 Deficiency, and Propionic Acidemia. The leading clinical trial sponsors are Mendel Tuchman, University of California, Los Angeles, and University Hospitals Cleveland Medical Center.

Recent Clinical Trials for Methylmalonic Acid
Long-term Efficacy of Carglumic Acid in Organic Acidemia.National Taiwan University HospitalN/A
Carglumic Acid in Methylmalonic Acidemia and Propionic AcidemiaKing Abdullah International Medical Research CenterPhase 3
EPI-743 in Cobalamin C Defect: Effects on Visual and Neurological ImpairmentCatholic University of the Sacred HeartPhase 2

See all Methylmalonic Acid clinical trials

Clinical Trial Summary for Methylmalonic Acid

Top disease conditions for Methylmalonic Acid
Top clinical trial sponsors for Methylmalonic Acid

See all Methylmalonic Acid clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.